Galera Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.42; its P/E ratio is -0.13; Galera Therapeutics is scheduled to report earnings on May 14, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -4.88M	$ -12.99M	$ -16.31M	$ -13.49M	$ -13.18M
EBITDA	$ -4.67M	$ -12.97M	$ -16.30M	$ -13.47M	$ -13.17M
Net Income Common Stockholders	$ -5.59M	$ -10.90M	$ -20.71M	$ -17.71M	$ -16.33M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 18.26M	$ 28.36M	$ 38.76M	$ 47.75M	$ 31.65M
Total Assets	$ 26.14M	$ 37.78M	$ 48.28M	$ 59.71M	$ 44.04M
Total Debt	$ 1.25M	$ 1.29M	$ 1.32M	$ 0.00	$ 44.00K
Net Debt	$ -17.01M	$ -27.08M	$ -37.43M	$ -47.75M	$ -31.60M
Total Liabilities	$ 157.33M	$ 164.33M	$ 163.28M	$ 157.33M	$ 153.22M
Stockholders Equity	$ -131.19M	$ -126.55M	$ -114.95M	$ -97.58M	$ -109.18M
Cash Flow	-
Free Cash Flow	$ -9.92M	$ -12.52M	$ -10.80M	$ -11.67M	$ -13.95M
Operating Cash Flow	$ -9.91M	$ -12.52M	$ -10.75M	$ -11.67M	$ -13.95M
Investing Cash Flow	$ 3.98M	$ 10.46M	$ 7.55M	$ 5.30M	$ 2.78M
Financing Cash Flow	$ -232.00K	$ 2.13M	$ 1.81M	$ 27.78M	$ 2.70M

Currency in USD

Galera Therapeutics Earnings and Revenue History

Income Statement >

Galera Therapeutics Debt to Assets

Balance Sheet >

Galera Therapeutics Cash Flow

Cash Flow >

Galera Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing